Results 81 to 90 of about 3,437 (244)

Computer-guided concentration-controlled trials in autoimmune disorders [PDF]

open access: yes, 1993
A randomized concentration-controlled clinical trial (RCCCT) is an alternate experimental design to the standard dose-controlled study. In a RCCCT, patients are randomly assigned to predefined plasma or blood drug concentration ranges (low, medium, and ...
Doyle, H   +7 more
core   +1 more source

Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database

open access: yesDermatology and Therapy, 2023
Introduction Alopecia areata (AA) is an autoimmune disease with an underlying immuno-inflammatory pathogenesis. Treatments can include systemic corticosteroids and immunomodulators (such as Janus kinase inhibitors); these medications may be associated ...
Prethibha George   +7 more
doaj   +1 more source

Adiponectin as a novel biomarker of disease severity in alopecia areata

open access: yesScientific Reports, 2021
The frequent coexistence of obesity and metabolic syndrome in patients with alopecia areata may indicate the common pathogenetic pathway in these conditions with an important role of adipokines.
Anna Stochmal   +6 more
doaj   +1 more source

Minimal clones generated by majority operations [PDF]

open access: yesAlgebra Universalis 44 (2000) 15-26, 2011
We determine all majority operations on a four-element set that generate a minimal clone.
arxiv  

Relapsing Polychondritis Following Alopecia Areata [PDF]

open access: yes, 2010
A case of alopecia areata followed by relapsing polychondritis is presented. Similar cases from the literature are reviewed and speculation about the relationship of these diseases is offered. Although the occurrence of these diseases together could be
Brasher, George W.   +2 more
core   +3 more sources

Association of Alopecia Universalis, Generalized Vitiligo, and Graves' Disease

open access: yesJournal of Research in Medical Sciences, 2005
We present a 21-years old woman with alopecia universalis, generalized vitiligo, and Graves' disease. She had had thyroidectomy in early childhood and was receiving replacement therapy with levothyroxine.
Z Shahmoradi   +2 more
doaj  

ALOPECIA UNIVERSAL COMO PRESENTACIÓN INICIAL DE UN SÍNDROME POLIGLANDULAR AUTOINMUNE REPORTE DE CASO

open access: yesMedicina, 2018
Introducción: La alopecia universalis es la pérdida de pelo en todo el cuerpo por destrucción del folículo capilar. En la etiología se describen factores 1. Genéticos como alteración del cromosoma 18, haplotipos HLA DQ3, DQ7, DR4 y DR11. 2.
Liliana M. Mejía Zapata   +1 more
doaj  

Representations of distributive semilattices in ideal lattices of various algebraic structures [PDF]

open access: yesAlgebra Universalis 45 (2001) 71--102, 2000
We study the relationships among existing results about representations of distributive semilattices by ideals in dimension groups, von Neumann regular rings, C*-algebras, and complemented modular lattices. We prove additional representation results which exhibit further connections with the scattered literature on these different topics.
arxiv  

A Generalization of Moufang and Steiner Loops [PDF]

open access: yesAlgebra Universalis 48 (2002), no. 1, 81--101, 2001
We study a variety of loops, RIF, which arise naturally from considering inner mapping groups, and a somewhat larger variety, ARIF. All Steiner and Moufang loops are RIF, and all flexible C-loops are ARIF. We show that all ARIF loops are diassociative, thus generalizing Moufang's Theorem.
arxiv  

Semilinear substructural logics with the finite embeddability property [PDF]

open access: yesarXiv, 2016
In this paper, three semilinear substructural logics ULw, IULw and HpsUL*w are constructed. Then the completeness of ULw and IULw with respect to classes of finite UL and IUL-algebras, respectively, is proved. Algebraically, non-integral ULw and IULw-algebras have the finite embeddability property, which gives a characterization for finite UL and IUL ...
arxiv  

Home - About - Disclaimer - Privacy